Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Fleming, M. T.; Molina, A. M.; Wolf, S. P.; de Leeuw, R.; Fernandez, C.; Kang, P.; Southwell, T.; Jones, C. L.; Fernandez, E.; Kelly, W. K. |
| Abstract Title: | Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900154 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.84 |
| Notes: | Meeting Abstract: 84 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
